Uncategorised - European Medical Journal

Deep-Learning Models Could Improve Hepatocellular Carcinoma Prognosis

Deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in hepatocellular carcinoma.

At-Home Smell Test Detects Early Cognitive Decline in Alzheimer’s

A new study reveals how an at-home smell test can detect early cognitive decline, aiding Alzheimer’s screening.

Reduced-Dose Apixaban Effective for Cancer-Related Blood Clots

Reduced-dose apixaban prevents recurrent blood clots in cancer patients, with fewer bleeding complications, offering a safer treatment option.

The Role of Sleep Quality in Geriatric Type 2 Diabetes Management

Poor sleep quality in geriatric type 2 diabetes patients is linked to worse glycaemic control and complications.

Maternal Flu Vaccination: Reducing Risks for Newborns

Beyond antibody transfer through the placenta, breastfeeding may further enhance infant protection.

Long-Term Lung Damage After Severe COVID-19: New Findings

Patients recovering from severe COVID-19 pneumonia may experience persistent lung function impairment long after hospital discharge, with new research highlighting vascular dysfunction as a key driver of long-term damage.

RSV Co-Infections Drive ICU Admissions in Hospitalized Children

Respiratory syncytial virus (RSV) remains a leading cause of pediatric respiratory infections, with a new study highlighting its widespread co-infections and severe clinical outcomes in hospitalized children.

How Juvenile Arthritis Disrupts Puberty in Children

Children with juvenile idiopathic arthritis (JIA) face more than just joint pain, emerging research reveals that the condition may significantly delay puberty.

New Ultrasound Treatment Significantly Reduces Acne Scars

A novel high-intensity, high-frequency ultrasound device has demonstrated significant effectiveness in reducing facial acne scars, according to a new clinical study.

Gene Therapy Shows Promise for Liver Disease Treatment

A recent first-in-human gene therapy trial using DTX401 has shown promising results in improving glucose homeostasis.